Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Website News
February 9, 2004
- BULLETIN
February 9, 2004
- Gov't-managed Health Insurance Reports 1st Surplus in 10 Yrs
February 9, 2004
- Cultural Sensitivity Is Very Important: Mr Mazzo of AMO
February 9, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 9, 2004
- M-VAC Therapy Approved
February 9, 2004
- Anunal Business Results
February 9, 2004
- Approval of 15 New Drugs Notified
February 9, 2004
- Semi-anunal Business Results
February 9, 2004
- Iryo Proverbs Reveal Japanese Spirit (17)
February 2, 2004
- Korosho Policies to Support Pharmaceutical Research Explained: Symposium
February 2, 2004
- Taisho Toyama Making Radical Changes in Marketing Strategy
February 2, 2004
- Six-year Interim Report of Japan Diabetes Complications Study Published
February 2, 2004
- Semi-annual Business Results
February 2, 2004
- Korosho to Approve Drug Sales by TV Phone on April 1
February 2, 2004
- Kuraya Sanseido Integrating Systems, Marketing Strategies Newly Start on Oct. 1
February 2, 2004
- BULLETIN
February 2, 2004
- FJPWA to Study Ways to Ensure Stable Profits for Wholesalers
February 2, 2004
- MEDICAL DEVICE NEWS IN BRIEF
February 2, 2004
- Biotech-related Market to Reach \1.1 Trillion in 2010: Fuji Keizai
February 2, 2004
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…